1. Corporate Officers - B
2. Brady Todd C

Insider Trading History of Brady Todd C

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Brady Todd C since 2016. This trader's CIK number is 1579179. At the time of last reporting, Brady Todd C was the President and CEO of Aldeyra Therapeutics, Inc.. (stock ticker symbol ALDX). Also see all insider trading activities at Aldeyra Therapeutics, Inc..

Note that in the past Brady Todd C also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Outlook Therapeutics, Inc. (ONS) by Brady Todd C

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2016	ONS	0	$0	0	$0	28,985	$0

Yearly summary of insider trading at Aldeyra Therapeutics, Inc. (ALDX) by Brady Todd C

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2026	ALDX	250,000	$418,500	0	$0	0	$0
2024	ALDX	0	$0	183,238	$580,808	0	$0
2023	ALDX	0	$0	0	$0	273,058	$150,728
2022	ALDX	17,700	$59,542	0	$0	0	$0
2019	ALDX	84,678	$465,101	0	$0	0	$0
2017	ALDX	22,223	$100,003	0	$0	0	$0

Insider trading activities at 2 companies by Brady Todd C:

1. Outlook Therapeutics, Inc. (ONS)

2. Aldeyra Therapeutics, Inc. (ALDX)

Table 1. Insider trading of Outlook Therapeutics, Inc. (ONS) by Brady Todd C

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2016-11-09	ONS	Option Ex	28,985	.00	0

Table 2. Insider trading of Aldeyra Therapeutics, Inc. (ALDX) by Brady Todd C

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2026-06-03	ALDX	Buy	250,000	1.67	418,500
2024-03-11	ALDX	Sale	97,914	3.27	320,570
2024-03-12	ALDX	Sale	85,324	3.05	260,238
2023-09-07	ALDX	Option Ex	273,058	.55	150,728
2022-06-23	ALDX	Buy	17,700	3.36	59,542
2019-12-16	ALDX	Buy	20,000	5.09	101,900
2019-09-30	ALDX	Buy	8,710	5.68	49,481
2019-09-23	ALDX	Buy	8,680	5.81	50,430
2019-09-18	ALDX	Buy	14,288	5.91	84,470
2019-09-13	ALDX	Buy	10,000	5.79	57,900
2019-09-16	ALDX	Buy	3,000	6.03	18,090
2019-09-09	ALDX	Buy	10,000	4.89	48,890
2019-09-10	ALDX	Buy	10,000	5.39	53,940
2017-02-17	ALDX	Buy	22,223	4.50	100,003

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brady Todd C (President and CEO of Aldeyra Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month